CM Life Sciences Overview
CM Life Sciences (CMLF) has a ROE of -43.55%, below the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow-43.55%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CM Life Sciences (CMLF) currently reports a ROE of -43.55%. That is below the sector sector average of 11.64%. Use the charts on this page to explore CM Life Sciences's ROE history and peer comparisons.
CM Life Sciences's ROE of -43.55% is lower than the its sector sector average of 11.64%. That is roughly 474.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CM Life Sciences's current -43.55% should be judged against industry norms (sector average: 11.64%) and against CMLF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -43.55%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for CM Life Sciences, and consider following CMLF for alerts when major investors trade the stock.
